OPKO Health (OPK) News Today $1.66 +0.02 (+1.22%) Closing price 04:00 PM EasternExtended Trading$1.65 -0.01 (-0.60%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period OPKO Health (OPK) Expected to Announce Earnings on ThursdayFebruary 26 at 1:57 AM | americanbankingnews.comOPKO Health (OPK) to Release Earnings on ThursdayOPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666426)February 25 at 1:32 AM | marketbeat.comOPKO Health Sees Unusually High Options Volume (NASDAQ:OPK)February 25 at 1:05 AM | americanbankingnews.comInvestors Buy High Volume of Call Options on OPKO Health (NASDAQ:OPK)OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw unusually large options trading activity on Monday. Investors bought 9,645 call options on the stock. This represents an increase of 402% compared to the average daily volume of 1,921 call options.February 24 at 11:27 AM | marketbeat.comOPKO Health (OPK) to Release Earnings on TuesdayOPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666426)February 18, 2025 | marketbeat.comIs Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy?February 12, 2025 | msn.comY.D. More Investments Ltd Sells 318,077 Shares of OPKO Health, Inc. (NASDAQ:OPK)Y.D. More Investments Ltd decreased its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 18.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,395,768 shares of the biotechnology company's stock after selling 318,077 shares duFebruary 5, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Sees Strong Trading Volume - Should You Buy?OPKO Health (NASDAQ:OPK) Sees Large Volume Increase - Still a Buy?February 3, 2025 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 47,537 SharesJanuary 29, 2025 | insidertrades.comOpko health CEO Phillip Frost buys $70,060 in stockJanuary 28, 2025 | msn.comPhillip Md Et Al Frost Buys 47,537 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 47,537 shares of the stock in a transaction dated Tuesday, January 28th. The shares were bought at an average price of $1.47 per share, for a total transaction of $69,879.39. Following the transaction, the chief executive officer now owns 213,234,014 shares in the company, valued at approximately $313,454,000.58. This represents a 0.02 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.January 28, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 634,254 Shares of OPKO Health, Inc. (NASDAQ:OPK)Assenagon Asset Management S.A. lessened its stake in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 42.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 856,738 shares of the biotechnology company's stock after selling 634,254 shares duringJanuary 24, 2025 | marketbeat.comBillionaire Phillip Frost's health care company settles case with federal governmentJanuary 22, 2025 | bizjournals.comOPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside PotentialJanuary 20, 2025 | insidermonkey.comOpko, BioReference to pay over $700K to resolve False Claims Act allegationsJanuary 18, 2025 | markets.businessinsider.comPhillip Md Et Al Frost Acquires 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockJanuary 18, 2025 | insidertrades.comBioReference faces $704,349 fine for medically unnecessary blood testsJanuary 18, 2025 | msn.comOpko health CEO Phillip Frost buys $220,425 in common stockJanuary 17, 2025 | msn.comPhillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 150,000 shares of the company's stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $1.47 per share, for a total transaction of $220,500.00. Following the transaction, the chief executive officer now owns 213,186,477 shares of the company's stock, valued at $313,384,121.19. This trade represents a 0.07 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.January 17, 2025 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Acquires $740,000.00 in StockJanuary 16, 2025 | insidertrades.comBarclays PLC Boosts Stock Position in OPKO Health, Inc. (NASDAQ:OPK)Barclays PLC grew its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 154.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 543,336 shares of the biotechnology company's stock after buying an additional 329,870 shaJanuary 16, 2025 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Buys $740,000.00 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 500,000 shares of the stock in a transaction on Wednesday, January 15th. The shares were bought at an average cost of $1.48 per share, with a total value of $740,000.00. Following the purchase, the chief executive officer now owns 213,036,477 shares of the company's stock, valued at $315,293,985.96. This trade represents a 0.24 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.January 15, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Downgraded to "Sell" Rating by StockNews.comStockNews.com downgraded OPKO Health from a "hold" rating to a "sell" rating in a research report on Wednesday.January 15, 2025 | marketbeat.comOPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | globenewswire.comOpko Health’s Promising Pipeline: Buy Rating Backed by Innovative Trials and Strategic CollaborationsJanuary 9, 2025 | markets.businessinsider.comOPKO Health's (OPK) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $3.00 price objective on shares of OPKO Health in a report on Wednesday.January 8, 2025 | marketbeat.comOPKO Health (NASDAQ:OPK) Upgraded by StockNews.com to "Hold" RatingStockNews.com upgraded OPKO Health from a "sell" rating to a "hold" rating in a report on Tuesday.January 7, 2025 | marketbeat.comOpko Health subsidiary announces EBV vaccine enters Phase I studyJanuary 7, 2025 | markets.businessinsider.comOPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with MerckJanuary 7, 2025 | finance.yahoo.comOPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume - Still a Buy?OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume - Should You Buy?January 6, 2025 | marketbeat.comGeode Capital Management LLC Lowers Stake in OPKO Health, Inc. (NASDAQ:OPK)Geode Capital Management LLC cut its position in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 5.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,374,745 shares of the bDecember 31, 2024 | marketbeat.comHow IBD Stock Of The Day GeneDx Landed On The IBD 50 And Notched A 2,500% GainDecember 31, 2024 | msn.com3 Stocks That Wall Street Insiders Can’t Stop BuyingInsider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.December 30, 2024 | marketbeat.comShort Interest in OPKO Health, Inc. (NASDAQ:OPK) Decreases By 14.0%OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 84,800,000 shares, a decrease of 14.0% from the November 30th total of 98,570,000 shares. Approximately 27.4% of the company's shares are sold short. Based on an average daily volume of 3,950,000 shares, the short-interest ratio is presently 21.5 days.December 30, 2024 | marketbeat.comState Street Corp Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK)State Street Corp lessened its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 8.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715,510 shares of the biotechnology cDecember 26, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Stock Rating Lowered by StockNews.comStockNews.com lowered OPKO Health from a "hold" rating to a "sell" rating in a research note on Thursday.December 26, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.comStockNews.com upgraded shares of OPKO Health from a "sell" rating to a "hold" rating in a research report on Wednesday.December 18, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 125,000 SharesDecember 14, 2024 | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Buys $198,750.00 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 125,000 shares of OPKO Health stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $1.59 per share, for a total transaction of $198,750.00. Following the completion of the transaction, the chief executive officer now directly owns 212,536,477 shares in the company, valued at $337,932,998.43. This trade represents a 0.06 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.December 13, 2024 | marketbeat.comPhillip Md Et Al Frost Purchases 500,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockDecember 12, 2024 | insidertrades.comCharles Schwab Investment Management Inc. Sells 835,569 Shares of OPKO Health, Inc. (NASDAQ:OPK)Charles Schwab Investment Management Inc. trimmed its holdings in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 16.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,212,355 shares of the biotecDecember 12, 2024 | marketbeat.comIs OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?December 11, 2024 | insidermonkey.comNextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerDecember 10, 2024 | finance.yahoo.comOPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years agoDecember 8, 2024 | finance.yahoo.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 199,072 Shares of StockNovember 30, 2024 | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Purchases $304,580.16 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 199,072 shares of the firm's stock in a transaction that occurred on Friday, November 29th. The stock was bought at an average cost of $1.53 per share, with a total value of $304,580.16. Following the completion of the purchase, the chief executive officer now owns 211,911,477 shares of the company's stock, valued at $324,224,559.81. This represents a 0.09 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.November 29, 2024 | marketbeat.comRubric Capital Management LP Acquires 4,284,336 Shares of OPKO Health, Inc. (NASDAQ:OPK)Rubric Capital Management LP grew its stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 9.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,706,640 shares of the biotechnology company's stockNovember 27, 2024 | marketbeat.comPhillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 100,000 shares of the stock in a transaction on Friday, November 22nd. The shares were bought at an average price of $1.59 per share, for a total transaction of $159,000.00. Following the purchase, the chief executive officer now owns 211,712,405 shares in the company, valued at approximately $336,622,723.95. This trade represents a 0.05 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.November 22, 2024 | marketbeat.comOPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 20, 2024 | markets.businessinsider.comNextPlat (NASDAQ: NXPL) Expands OPKO Product Promotion at Asia’s Largest Health ExpoNovember 19, 2024 | theglobeandmail.com Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos OPK Media Mentions By Week OPK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPK News Sentiment▼0.550.53▲Average Medical News Sentiment OPK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPK Articles This Week▼53▲OPK Articles Average Week Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FOLD News Today LGND News Today DVAX News Today BCRX News Today MNKD News Today GERN News Today CLDX News Today MYGN News Today NVAX News Today INVA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPK) was last updated on 2/26/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMust-See: Trump’s Shocking AI AnnouncementIf you have any investments in AI stocks or are interested in AI… Please take a moment to review the detail...Brownstone Research | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredThe U.S. is About to Run Out of Money… Again.Treasury Warns America is Nearing Bankruptcy Discover the harmful impact on your retirement savings… True Gold Republic | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPK Stock Alerts